Navigation Links
Docs Say No to Pulling Drugs Containing Acetaminophen off the Market

FLEMINGTON, N.J., July 20 /PRNewswire/ -- A new national media study among 589 physicians revealed that the majority of physicians (82%) do not believe that drugs containing acetaminophen should be pulled off the market.

(Logo: )

The study was conducted by HCD Research using its website during July 17-19, to obtain physicians' perceptions of a CNN news clip which outlined an FDA committee's recent concern regarding acetaminophen, a drug found in several common prescription and non-prescription products. To view agreement curves and detailed results go to:

"Physicians expressed sharp disagreement when the CNN reporter stated: 'the committee said yank them off the market -- no more Vicodin, no more Percocet,' as evidenced by the downward spiral of our automated response curves," explained Glenn Kessler, president and CEO, HCD Research.

The majority of doctors (70%) reported that the FDA's warnings and concerns regarding the acetaminophen have not affected their prescribing habits.

Among the findings:

"Have your prescribing habits changed since becoming aware of the FDA's recent warnings and concerns regarding the drug Acetaminophen? Select all that apply."

    More likely to prescribe products containing
     Acetaminophen                                          1%

    Less likely to prescribe products containing
     Acetaminophen                                          8%

    More likely to discuss warnings and dosage
     instructions with patients who are prescribed
     or use Acetaminophen products                         29%

    No change in prescribing habits for products
     containing Acetaminophen                              70%

    Other                                                   1%

"Do you think the FDA should pull Acetaminophen products?"

    Yes, both prescription and non-prescription
     Acetaminophen products                                 4%

    Yes, prescription Acetaminophen products only           6%

    Yes, non-prescription Acetaminophen products
     only                                                   3%

    Yes, they should pull only certain products
     containing Acetaminophen.                              6%

    No, they should not pull any Acetaminophen
     products                                              82%

While viewing the video, participants indicated their levels of agreement by moving their mouse from left to right on a continuum. The responses were recorded in quarter-second intervals and reported in the form of curves. The participants were also asked to respond to post-viewing questions.

HCD Research is a marketing and communications research company headquartered in Flemington, NJ. For additional information on HCD Research, access the company's website at ( is a media measurement website that provides the media and general public with a venue to view Americans' perceptions of popular and controversial media events and advertisements.

Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. A Magnetic Presence: Siemens New MRI Systems Pulling More Patients Toward the Benefits of MR Imaging
2. High-Salt Diet Dampens Effects of Blood Pressure Drugs
3. Debate Over Advertising Prescription Drugs to Consumers Goes Online at New Website
4. Crime, Drugs and Health Problems Face Vancouvers Downtown Eastside
5. CMPI to Host Hill Briefing Tomorrow on Follow-on Biologic Drugs for Media and Congressional Staff With Reps. Eshoo and Rogers
6. China Nepstar Chain Drugstore Acquires Drugstores in Beijing
7. The National Council on Aging and CVS/pharmacy Educate Tampa Seniors on Medication Management and How to Save Money on Prescription Drugs
8. Dry mouth linked to prescription and over the counter drugs
9. CMPI to Host Hill Briefing on Follow-On Biologic Drugs for Media and Congressional Staff with Reps. Eshoo and Rogers
10. Post-transplant combo can replace toxic immune-suppressing drugs in monkeys
11. New York Law Firm Files Lawsuit Against Manufacturer of Zicam Nasal Spray and Drugstore Chain That Sold Product
Post Your Comments:
(Date:11/25/2015)... , ... November 25, 2015 , ... On November 10, ... States District Court of Connecticut on behalf of a home health care worker who ... current or former home health care workers employed by Humana, Inc., Humana at Home, ...
(Date:11/25/2015)... ... , ... On November 25, 2015, officials of Narconon Arrowhead , the ... of a new cutting edge recovery program that has been 50 years in the ... alcohol-addicted individuals with the purpose to free addicts from the symptoms and negative behaviors ...
(Date:11/25/2015)... ... , ... SCOTTSDALE, AZ) - Today, Dr. Todd C. ... and non-surgical treatments, announced the expansion of his private practice capabilities with the ... Highly trained and nationally recognized for his natural approach, Dr. Todd Hobgood serves ...
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... Today, ... on our nation’s roadways has dropped below 10,000 for the first time since 2011. ... in 2013. , According to data released by the National Highway Traffic Safety Administration ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... of philanthropic seniors, is resulting in a way for homeless people to have ... Schaumburg have launched a new initiative whereby they are repurposing plastic bags into ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... , November 25, 2015 ... due to repeated failure of IVF cycles. After failure ... was totally dejected and had lost all hopes that she would be able ... Indian miracle child conceived after failure of over 15 ... abroad (UK) before they decided to take one last attempt with ...
(Date:11/24/2015)... SAN CARLOS, Calif. , Nov. 24, ... ), a leader in non-invasive genetic testing ... today announced that it will present at ... Conference in New York on Wednesday, December 2, 2015 at 1:00 p.m. ... discuss the Company,s financial results, business activities ...
(Date:11/24/2015)... /PRNewswire/ - ESSA Pharma Inc. ("ESSA" or the "Company") ... the first patient has been enrolled in ESSA,s Phase ... metastatic castration-resistant prostate cancer ("mCRPC"). the ... the United States and Canada.  ... trial, ESSA intends to demonstrate the safety, tolerability, maximum ...
Breaking Medicine Technology: